Ann Arbor, MI, United States of America

Eric Kaldjian

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Eric Kaldjian and His Contributions to Immunohistochemistry

Introduction: Eric Kaldjian, based in Ann Arbor, MI, has made significant strides in the field of immunohistochemistry with his innovative methodologies. With a portfolio of three patents, Kaldjian continues to advance the science of tumor detection, focusing specifically on the nuances of primary antibody usage.

Latest Patents: Eric Kaldjian's most recent patents include groundbreaking methods that utilize multiplex immunohistochemical assays. His first patent outlines techniques for detecting CD3 and CD16 within a single sample of colorectal, head & neck, or lung tumors. This method employs primary antibodies from the same host species and secondary antibodies specifically reactive to those primary antibodies, enhancing the accuracy of the assays. His second patent expands on this concept by detailing methods for detecting two different epitopes simultaneously using similar immunohistochemical techniques. Both patents emphasize methods to denature and block the first primary antibody in contact with the sample, which is critical for improving assay performance.

Career Highlights: Eric is currently associated with Ventana Medical Systems, Inc., where he is instrumental in advancing immunohistochemical techniques. His innovative approaches have significantly contributed to the field and have been recognized through his patented methods for improved diagnostic accuracy.

Collaborations: Throughout his career, Kaldjian has collaborated with esteemed colleagues such as Jacquelyn Smith and Harry James Hnatyszyn at Ventana Medical Systems, Inc. These partnerships have been vital in fostering a creative environment that enhances research quality and innovation.

Conclusion: Eric Kaldjian exemplifies the role of a visionary inventor in the medical field. His work in multipurpose immunohistochemical assays underscores the importance of innovation in improving diagnostic methods for tumor detection. With ongoing contributions to research and development, Kaldjian continues to impact the healthcare industry positively, paving the way for more effective methodologies in immunohistochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…